In a recent letter, the Michigan Rheumatism Society and similar organizations from elsewhere in the U.S. have urged members of Congress to prioritize the development of predictive drug-response testing and other elements of precision medicine.
The model of precision medicine, also referred to as personalized care, calls for collecting and assessing information specific to a patient’s condition, including genetics, health history and living environment. Treatments and preventive measures prescribed after such analysis can then be better suited toward each individual. Heretofore, healthcare prescription has usually followed a one-size-fits-all paradigm that doesn’t work best for every patient.
Read More